President Donald Trump and House Speaker Nancy Pelosi don't agree on much. But they've both made it clear they believe Americans pay too much for prescription drugs. To trim drug spending, one of Pelosi's top aides is working quietly with the White House on a cost-control measure known as "binding arbitration."